RSV vaccine Phase 1 study to begin
by Press Release from Outbreak News Today on (#3SAPW)
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus (RSV). The Phase 1 study will enroll a small group of healthy adult volunteers to examine the safety of an experimental intranasal vaccine and ["]
The post RSV vaccine Phase 1 study to begin appeared first on Outbreak News Today.